Form 4: Biote Corp. Director Dana Lynn Jacoby Reports Stock Transactions

Director Dana Lynn Jacoby reports acquisition and disposal of Biote Corp. stock and derivative securities.

Summary

• On May 21, 2024, Dana Lynn Jacoby, a director of Biote Corp., reported transactions involving the company's stock.
• Jacoby acquired 11,595 shares of Class A Common Stock through the vesting of Deferred Settlement RSUs and disposed of the same amount.
• Following the transaction, Jacoby directly owns 50,970 shares of Class A Common Stock.
• Jacoby also acquired 12,994 Deferred Settlement RSUs that will be settled in Class A Common Stock, and was granted an option to buy 65,258 shares of Class A Common Stock at an exercise price of $5.57, vesting on the earlier of May 21, 2025, or the day prior to the Issuer's 2025 Annual Meeting of Stockholders.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by a company director, which is a routine occurrence.

Positives

• The granting of stock options and RSUs to directors can be seen as a positive sign, aligning their interests with those of the shareholders.

Future Outlook

Settlement of the Deferred Settlement RSUs will occur in either calendar year 2025 or upon the Reporting Person's separation from service. The stock options will vest on the earlier of May 21, 2025, or the day prior to the Issuer's 2025 Annual Meeting of Stockholders, subject to continuous service.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the actions of company leadership.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider activity.
• The granting of stock options and RSUs aligns the director's interests with those of the shareholders.

Key Dates